Leishmaniasis: Clinical Trials

8 trials for Leishmaniasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed. 8 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 48Completed 8

Follow Leishmaniasis: new trials by email Literature Review of Leishmaniasis trials Research Report on Leishmaniasis

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Effectiveness of Short-course AmBisome in the Treatment of PKDL in Bangladesh
AmBisome - Post-kala-azar Dermal Leishmaniasis
Phase 4CompletedMedecins Sans Frontieres, Netherlands2802014-04-082017-10-17
A Study to Explore Association of Treatment Regimens for Visceral Leishmaniasis, Host Immunological, Genetical and Nutrition Factors With Post-kala-azar Dermal Leishmaniasis (PKDL)
Mitefosine - Post-kala-azar Dermal Leishmaniasis
Phase 4CompletedInternational Centre for Diarrhoeal Disease Research, Bangladesh362013-01-012014-11-05
Pharmacokinetics of Miltefosine in Children and Adults
Miltefosine - Cutaneous Leishmaniasis
Phase 4CompletedCentro Internacional de Entrenamiento e Investigaciones Médicas602011-10-012016-08-22
Efficacy of Radio-frequency Induced Heat (RFH)Therapy in Treatment of Cutaneous Leishmaniasis in India
RFH therapy, Sodium stibogluconate - Cutaneous Leishmaniasis
Phase 4CompletedSarder Patel Medical College1002009-08-012012-09-03
Low-dose Pentavalent Antimony Treatment of Cutaneous Leishmaniasis in Old Age Patients
Meglumine antimoniate - Localized Cutaneous Leishmaniasis
Phase 4CompletedUniversity of Brasilia132008-08-012010-10-08
Expand Access/Assess Safety and Efficacy of Paromomycin IM Injection for the Treatment of Visceral Leishmaniasis
Paromomycin sulfate - Visceral Leishmaniasis
Phase 4CompletedPATH20002007-10-012014-10-03
Amphotericin B to Treat Visceral Leishmaniasis in Brazilian Children
Meglumine antimoniate, Amphotericin B-deoxycholate - Visceral Leishmaniasis
Phase 4CompletedUniversity of Brasilia1012007-10-012017-09-05
Safety and Efficacy of Low-Dose Pentavalent Antimony for Treatment of Cutaneous Leishmaniasis
Meglumine antimoniate - Cutaneous Leishmaniasis
Phase 4CompletedUniversity of Brasilia2802006-02-012009-01-22

Narrower conditions

Leishmaniasis, Cutaneous (4)  ·  Leishmaniasis, Visceral (3)  ·  Hyperthermia (1)

Broader conditions

Euglenozoa Infections (8)  ·  Infections (8)  ·  Parasitic Diseases (8)  ·  Protozoan Infections (8)  ·  Vector Borne Diseases (8)  ·  Skin Diseases (5)  ·  Skin Diseases, Infectious (5)  ·  Skin Diseases, Parasitic (5)  ·  Skin and Connective Tissue Diseases (5)  ·  Body Temperature Changes (1)  ·  Heat Stress Disorders (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Wounds and Injuries (1)

Interventions

Meglumine Antimoniate (3)  ·  Amphotericin B (1)  ·  Antimony Sodium Gluconate (1)  ·  Diathermy (1)  ·  Paromomycin (1)  ·  Pharmacogenomic Variants (1)  ·  amphotericin B, deoxycholate drug combination (1)  ·  liposomal amphotericin B (1)  ·  miltefosine (1)

Sponsors

University of Brasilia (3)  ·  Centro Internacional de Entrenamiento e Investigaciones Médicas (1)  ·  International Centre for Diarrhoeal Disease Research, Bangladesh (1)  ·  Medecins Sans Frontieres, Netherlands (1)  ·  PATH (1)  ·  Sarder Patel Medical College (1)

Countries

Brazil (3)  ·  India (2)  ·  Bangladesh (1)  ·  Colombia (1)

Top investigators

Amrendra K Aditya, MD (1)  ·  C P Thakur, MD (1)  ·  Devendra Nath, MD (1)  ·  Dinesh Mondal, MB; MD; PhD (1)  ·  Gustavo AS Romero, PhD (1)  ·  Gustavo Adolfo S Romero, MD, PhD (1)  ·  Gustavo S Romero, MD (1)  ·  Julia S Ampuero-Vela, MD, MSc (1)  ·  Koert Ritmeijer, PhD (1)  ·  Myrlena RM Borges, MsC (1)  ·  Nancy C Saravia, PhD (1)  ·  P K Sinha, MD (1)  ·  Ram A Bumb, MD (1)  ·  Shyam Sundar, MD (1)  ·  Supriyo Mukherjee, MD (1)

Results publications

PMID 27956421, PMID 28327804, PMID 28379954